Fortress Biotech Inc

-0.22 (-8.30%)
Earnings Announcements

Fortress Biotech Reports Q3 GAAP Loss Per Share $0.26

Published: 11/15/2021 21:33 GMT
Fortress Biotech Inc (FBIO) - Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights.
Q3 GAAP Loss per Share $0.26.
Q3 Revenue Rose 123 Percent to $21.1 Million.
As of Sept 30, 2021, Co's Consolidated Cash, Cash Equivalents and Restricted Cash Totaled $254.4 Million.
Qtrly Non-GAAP Net Loss Attributable to Common Stockholders $0.19.
Qtrly Fortress Non-GAAP Income per Share Attributable to Common Stockholders $0.54.
Q3 Earnings per Share View $-0.08, Revenue View $18.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $39.64 Million
Adjusted EPS is expected to be $0.08

Next Quarter Revenue Guidance is expected to be $21.1 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.